ANGITEL is contra-indicated to patients with: Hypersensitivity to the active ingredients or any of the excipients; Second and third trimesters of pregnancy; Lactation; Biliary obstructive disorders; Severe hepatic impairment.
The concomitant use of Telmisartan with aliskiren is contra-indicated in patients with diabetes mellitus or renal impairment (GFR < 60 mL/ min/1.73 m2).
In case of rare hereditary conditions that may be incompatible with an excipient of the product (refer to PRECAUTIONS), the use of the product is contra-indicated.
Other Services
Country
Account